Table 2 Endometrial assessment of nine independent patients utilising the ERS2
ERS2 | Patients | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Normal | RIF and/or RPL | |||||||||||||
Main-Criteria | Sub-Criteria | Full Points | #1 | #2 | #3 | #4 | #5 | #6 | #A | #B | #C | #D | #E | #F |
Endometrial Receptivity | Intensity of Integrin αvβ3 | 5 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 3 | 2 | 3 |
Intensity of Osteopontin | 5 | 4 | 3 | 3 | 4 | 4 | 4 | 1 | 3 | 1 | 2 | 3 | 3 | |
Blood vessel formation | Area of angiogenic sprout | 5 | 3 | 3 | 4 | 4 | 4 | 3 | 1 | 3 | 1 | 1 | 1 | 1 |
Area of blood vessel | 5 | 4 | 4 | 4 | 4 | 3 | 4 | 1 | 4 | 1 | 3 | 2 | 1 | |
Total | 20 | 15 | 13 | 14 | 15 | 15 | 14 | 6 | 12 | 5 | 9 | 8 | 8 | |
ERS2 | Â | Receptive | Receptive | Receptive | Receptive | Receptive | Receptive | Non-Receptive | Receptive | Non-Receptive | Non-Receptive | Non-Receptive | Non-Receptive | |
ERS2: IVF-ET outcome prediction | Â | Success | Success | Success | Success | Success | Success | Fail | Success | Fail | Fail | Fail | Fail | |
Clinical pregnancy outcome | Â | Success | Success | Success | Success | N/A | N/A | Fail | Success | Fail | Fail | Fail | N/A | |
